At Symeres, safety is embedded in every step of drug development. With over 35 years of experience in pharmaceutical synthesis, we know that early, thorough attention to process safety ensures not only the protection of personnel and the environment, but also the successful and timely delivery of high-quality APIs.
In this white paper, we share how our structured, proactive approach to process safety enables safe scale-up, minimizes risk, and ensures regulatory compliance. Learn how we integrate advanced risk assessment methods, innovative technologies like flow chemistry, and real-time safety monitoring into every stage of development from initial design to full-scale manufacturing.
